mRNA Capping Efficiency Quantification via Hybridization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining mRNA capping efficiency in IVT reaction mixtures are either costly, sample-inefficient, or time-consuming, particularly due to the need for radiolabeling or costly reagents and the complexity of pre-processing samples.
Innovation Solution
A method combining mRNA:DNA hybridization, nuclease cleavage, and MS/LC-MS quantification in a single reaction vessel to accurately and efficiently quantify capping efficiency by enzymatically releasing the first five to seven 5' nucleotides of mRNA transcripts, allowing for direct analysis without pre-processing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radiolabeling methods are used to determine capping efficiency, then measurement precision is improved, but loss of substance increases due to prohibition of mRNA sample use in downstream applications and requirement for separate control reactions
Solution Approach 1:
The method extracts and analyzes only the first 5-7 nucleotides at the 5' end of mRNA transcripts through enzymatic release, separating the analysis target from the bulk mRNA sample. This allows precise capping efficiency measurement while preserving the majority of the mRNA sample for downstream applications, resolving the contradiction between measurement precision and sample availability.
Solution Approach 2:
The method segments the mRNA transcript into a small 5' end fragment (5-7 nucleotides) containing the cap structure and the remaining body. By analyzing only this segmented portion through hybridization and nuclease cleavage, the method achieves precise cap structure detection without consuming the entire mRNA sample, thus maintaining sample availability for other purposes.
2Measurement precision
If oligonucleotide probe methods with magnetic bead enrichment are used, then measurement precision is improved, but device complexity and loss of substance increase due to additional reagents and yield reduction
Solution Approach 1:
The method takes out the analysis function from complex enrichment procedures and performs it directly through hybridization of an oligonucleotide probe to the 5' end of mRNA, followed by nuclease cleavage. This eliminates the need for magnetic bead enrichment steps, reducing device complexity while maintaining precision in cap structure detection.
Solution Approach 2:
The method merges multiple functions into a single integrated procedure: the oligonucleotide probe simultaneously serves as a hybridization target and a guide for nuclease cleavage, while the same reaction vessel accommodates all steps. This consolidation eliminates separate enrichment steps and reduces overall assay complexity while preserving measurement precision.
3Measurement precision
If multiple separate samples are processed for simultaneous analysis, then measurement precision is improved, but loss of time increases due to increased processing steps and intra-operator variability
Solution Approach 1:
The method merges multiple analysis steps into a single reaction vessel, where the oligonucleotide probe hybridization, nuclease cleavage, and cap structure analysis all occur in one integrated assay. This eliminates the need for multiple separate samples and parallel processing, significantly reducing assay time and minimizing intra-operator variability while maintaining measurement precision.
Solution Approach 2:
The method performs preliminary hybridization of the oligonucleotide probe to the 5' end of mRNA transcripts before nuclease cleavage. This preliminary action positions the probe to guide subsequent selective cleavage and analysis, enabling all measurements to be performed on a single prepared sample rather than requiring multiple separate preparations, thus reducing time loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a reliable, quick, and cost-effective method for assessing mRNA capping efficiency, suitable for quality control in mRNA manufacture and as an active pharmaceutical ingredient, with high sensitivity and specificity for Cap 1 structure determination.
Implementation Method 1
contacting the mRNA sample with an oligonucleotide complementary to the mRNA transcripts to form an mRNA:DNA hybrid
Implementation Method 2
contacting the sample obtained in step (b) with nuclease (e.g., RNase H) to release (i) the first five 5' nucleotides of the mRNA
Data Source
AI summary
The invention relates to a method of quantifying capping efficiency in a sample from an in vitro transcription reaction mixture comprising a plurality of mRNA transcript, characterized by a step of contacting the mRNA transcripts with an oligonucleotide complementary to a sequence of nucleotides in the 5′ untranslated region of the mRNA transcripts to form an mRNA:DNA hybrid between the oligonucleotide and the sequence of nucleotides of the mRNA transcripts in order to release the first five, six, or seven nucleotides of the mRNA transcripts using nuclease (e.g., RNAse H) digestion.